Biologicals & Biosimilars Manufacturing Facility to Egypt

Published Tuesday, July 5, 2022











Pharmadule Morimatsu will deliver a modular turn-key facility to Egyptian International Pharmaceutical Industries, EIPICO, for a biological & biosimilar manufacturing facility in Tenth of Ramadan City, Egypt.

The EIPICO 3 facility will be largest and first factory in Egypt and the Middle East to produce biologicals and biosimilars alternatives and medicines in the 10th of Ramadan City with an area of 10.000 SQM. EIPICO 3 will manufacture biological products, monoclonal antibodies (MABs) and biopharmaceutical proteins.











The project & commercial Team members of EIPICO, Pharmadule Morimatsu and United Group.

Back to news
Pharmadule Morimatsu AB  |   DanvikCenter 28  |   SE - 131 30 Nacka  Sweden  |   Phone: +46 (0)8 587 42 000  |   Email: